In a major boost to Seattle’s biotech community, which this year alone has seen more than 280 workers lose their jobs, Danish drug giant Novo Nordisk is opening a research site here.
In a major boost to Seattle’s biotech community, which this year alone has seen more than 280 workers lose their jobs, Danish drug giant Novo Nordisk is opening a research site here.
